Home Support ISMP Newsletters Webinars Report Errors Educational Store Consulting FAQ Tools About Us Contact Us
ISMP Facebook

The following are excerpts from the newsletter

January 15, 1996

  • FDA issues final rule for medical device reporting
  • Cozaar® - Zocor®:Drug name issue
  • Put ISMP Medication Safety Alert! to work
  • Institute coordinates chemotherapy error prevention practice recommendations
  • Abbreviation used for Caverject® (alprostadil) leads to drug ID problem
  • Brevibloc® (esmolol) revised packaging available

January 31, 1996

  • Urgent! ACTION REQUIRED Accidents with 30 mL epinephrine vials
  • National Coordinating Council for Medication Error Reporting and Prevention established
  • Regitine production temporarily halted by FDA action
  • Caution needed when administering PRIMACOR® (milrinone) INFUSION loading dose
    • Safety Briefs:
    • Amrinone-Amiodarone mix-up leads to death.
    • Anecdotal reports have been received about precipitation when amiodarone is added to evacuated glass containers.
    • Your institution may wish to consider brightly colored labels to identify injection ports on epidural lines.
    • Doxil®, a new liposomal formulation of doxorubicin, sounds like "Paxil."
    • Are all of your clinical personnel aware of cross sensitivity between NSAIDs?
    • FDA labeling regulations for oral iron products containing 30 mg or more of elemental iron per tablet or capsule are being finalized

subscribe now

Acute Care Main Page
Current Issue
Past Issues
Highlighted articles
Action Agendas - Free CEs
Special Error Alerts
Newsletter Editions
Acute Care
Long Term Care
Home | Contact UsEmployment  | Legal Notices | Privacy Policy | Help Support ISMP
Med-ERRS Med-ERRS | MSOMedication Safety Officers Society | Consumer Medication SafetyFor consumers
 ISMP Canada ISMP Canada | ISMP Spain ISMP Spain | ISMP Brasil ISMP Brasil | International Group | Pennsylvania Patient Safety Authority

200 Lakeside Drive, Suite 200, Horsham, PA 19044, Phone: (215) 947-7797,  Fax: (215) 914-1492
© 2018 Institute for Safe Medication Practices. All rights reserved